Back to search
Generated on www.datasnoop.be
Dantestraat, 75, 1070 AnderlechtNACE 21201 — Vervaardiging van geneesmiddelen
Key FinancialsFY2024
Revenue
€451.2M
↑ 7.2%
EBITDA
€12.0M
↑ 5.3%
Margin
2.6%
Employees
133
↓ 8.3%
Leverage
1.2x
Net Debt / EBITDA
Equity Ratio
29.3%
Equity / Assets
Int. Coverage
8.8x
EBITDA / Int. Exp
DSO
91d
Days to collect
DPO
69d
Days to pay
Financial History Summary
| Year | Revenue | EBITDA | Margin | Net Profit | FTE |
|---|---|---|---|---|---|
| 2024 | €451.2M +€30.2M ▲ +7.2% | €12.0M +€599K ▲ +5.3% | 2.6% | €7.9M -€980K ▼ -11.1% | 133 -€12 ▼ -8.3% |
| 2023 | €421.0M +€0 ▲ +0.0% | €11.4M +€0 ▲ +0.0% | 2.7% | €8.9M +€0 ▲ +0.0% | 145 +€0 ▲ +0.0% |
| 2023 | €421.0M | €11.4M | 2.7% | €8.9M | 145 |
Key People
No administrator data
Recent Publications(162)
ONTSLAGEN - BENOEMINGEN
2025-11-28· #0151159
ONTSLAGEN - BENOEMINGEN
2025-01-31· #0016179
ONTSLAGEN - BENOEMINGEN
2024-07-18· #0108641
ONTSLAGEN - BENOEMINGEN
2024-04-19· #0063924
Publication
2024-01-19· #0333913
DEMISSIONS, NOMINATIONS
2023-06-30· #0084545
Key Shareholders
No shareholder data
Key Subsidiaries
No subsidiary data